Pfizer Wins $10B Metsera Acquisition Expands Obesity Treatment Pipeline
Pfizer secures a $10B deal to acquire Metsera, boosting obesity therapies and signaling strategic growth in biotech.
Latest right now for #biotech
Grad Student Sparks Aging Breakthrough with Shape-Shifting Aptamers
Mayo Clinic grad student unveils aptamer-based detection of senescent cells, signaling new anti-aging therapies.
NU-9 Halts Alzheimer's Progression in Groundbreaking Trial
NU-9 halts early-stage Alzheimer's in mouse models; early detection and biomarkers could boost treatment outcomes.
Google Ruling Impacts Market
A breakdown of Tuesday's market, including Google's antitrust ruling and standout performances from Nvidia, gold, and biotech stocks.
